Fixed dose combination therapy in the treatment of hypertension.
Stanton
T
T
Department of Medicine and Therapeutics, University of Glasgow, Glasgow, Scotland, UK.
Reid
J L
JL
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D004232:Diuretics; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011379:Prognosis; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors